Your care team at Miami Cancer Institute is made up of world-renowned oncologists who are experts in compassionate, effective cancer care. They will work side-by-side with you to develop a plan that fits your individual needs.
Our gynecologic cancer specialists have access to a range of cutting-edge technologies as well as weekly, multidisciplinary tumor boards where our gynecologic experts can collaborate on treatment plans.
The gynecologic oncologists at Miami Cancer Institute provide advanced whole-patient care. Each individualized care plan includes innovative treatments as well as services to address your entire journey as a patient, including nutritional advice, physical therapy and pain management services.
Uterine cancer is a disease in which cancerous (malignant) cells form in the uterus. These cancerous cells typically begin in the lining of the uterus known as the endometrium. Cancer that forms in the muscle of the uterus is known as uterine sarcoma.
In the United States, uterine cancer is the most common cancer of the female reproductive system and usually affects women after menopause.
The uterus is the hollow, pear-shaped organ where a fetus grows during pregnancy.
The most common type of uterine cancer is endometrioid adenocarcinoma. These cancers form in the glandular cells of the uterine lining.
Other forms of uterine cancer include:
The most common risk factor for uterine cancer is obesity. Women who have high levels of estrogen (usually from taking hormone replacement therapy) also have a high risk of developing the disease.
Other risk factors may include:
There is no guaranteed way to prevent cancer. However, you can reduce your risk for uterine cancer by:
While there is no standard screening for uterine cancer, you and your doctor can discuss a screening regimen if you have a high risk of developing uterine cancer due to genetic risk factors. At Miami Cancer Institute, our clinical genetics service can help identify patients at a high risk for developing certain gynecologic cancers.